NCT01737684View on ClinicalTrials.gov

A Single-Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Adults With Hepatic Insufficiency (MK-4618-013)

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 15, 2013

Primary Completion Date

June 14, 2013

Study Completion Date

June 14, 2013

Conditions
Overactive Bladder
Interventions
DRUG

Vibegron

50 mg tablet, oral

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT01737684 - A Single-Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Adults With Hepatic Insufficiency (MK-4618-013) | Biotech Hunter | Biotech Hunter